These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9761669)

  • 1. Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin.
    Skinner R; Chang WS; Jin L; Pei X; Huntington JA; Abrahams JP; Carrell RW; Lomas DA
    J Mol Biol; 1998; 283(1):9-14. PubMed ID: 9761669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
    Dementiev A; Petitou M; Herbert JM; Gettins PG
    Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimers initiate and propagate serine protease inhibitor polymerisation.
    Zhou A; Carrell RW
    J Mol Biol; 2008 Jan; 375(1):36-42. PubMed ID: 18005992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How small peptides block and reverse serpin polymerisation.
    Zhou A; Stein PE; Huntington JA; Sivasothy P; Lomas DA; Carrell RW
    J Mol Biol; 2004 Sep; 342(3):931-41. PubMed ID: 15342247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.
    Rezaie AR; Yang L; Manithody C
    Biochemistry; 2004 Mar; 43(10):2898-905. PubMed ID: 15005625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site.
    Skinner R; Abrahams JP; Whisstock JC; Lesk AM; Carrell RW; Wardell MR
    J Mol Biol; 1997 Feb; 266(3):601-9. PubMed ID: 9067613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.
    Huntington JA; Olson ST; Fan B; Gettins PG
    Biochemistry; 1996 Jul; 35(26):8495-503. PubMed ID: 8679610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of reactive centre loop length upon serpin polymerisation.
    Bottomley SP; Chang WS
    Biochem Biophys Res Commun; 1997 Dec; 241(2):264-9. PubMed ID: 9425260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological implications of a 3 A structure of dimeric antithrombin.
    Carrell RW; Stein PE; Fermi G; Wardell MR
    Structure; 1994 Apr; 2(4):257-70. PubMed ID: 8087553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobile reactive centre of serpins and the control of thrombosis.
    Carrell RW; Evans DL; Stein PE
    Nature; 1991 Oct; 353(6344):576-8. PubMed ID: 1922367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.
    Nar H; Bauer M; Stassen JM; Lang D; Gils A; Declerck PJ
    J Mol Biol; 2000 Mar; 297(3):683-95. PubMed ID: 10731421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.
    Whisstock JC; Pike RN; Jin L; Skinner R; Pei XY; Carrell RW; Lesk AM
    J Mol Biol; 2000 Sep; 301(5):1287-305. PubMed ID: 10966821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa.
    Wei A; Alexander RS; Duke J; Ross H; Rosenfeld SA; Chang CH
    J Mol Biol; 1998; 283(1):147-54. PubMed ID: 9761680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conformational activation of antithrombin. A 2.85-A structure of a fluorescein derivative reveals an electrostatic link between the hinge and heparin binding regions.
    Huntington JA; McCoy A; Belzar KJ; Pei XY; Gettins PG; Carrell RW
    J Biol Chem; 2000 May; 275(20):15377-83. PubMed ID: 10809774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2.6 A structure of a serpin polymer and implications for conformational disease.
    Huntington JA; Pannu NS; Hazes B; Read RJ; Lomas DA; Carrell RW
    J Mol Biol; 1999 Oct; 293(3):449-55. PubMed ID: 10543942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution.
    Mourey L; Samama JP; Delarue M; Petitou M; Choay J; Moras D
    J Mol Biol; 1993 Jul; 232(1):223-41. PubMed ID: 8331659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
    Björk I; Ylinenjärvi K; Olson ST; Bock PE
    J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.
    Elliott PR; Abrahams JP; Lomas DA
    J Mol Biol; 1998 Jan; 275(3):419-25. PubMed ID: 9466920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.